Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(15 sites)
United States
Stamford Hospital, Stamford, Connecticut Miami Cancer Institute at Baptist Health (Kendall), Miami, Florida Miami Cancer Institute at Baptist Health, Plantation, Florida University of Chicago Medical Center, Chicago, Illinois Eastern Maine Medical Center, Brewer, Maine Dana Farber Cancer Institute, Boston, Massachusetts DFCI @ Foxborough, Foxborough, Massachusetts DFCI @ Milford Regional Hospital, Milford, Massachusetts DF/BWCC in Clinical Affiliation with South Shore Hospital, South Weymouth, Massachusetts The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina The Christ Hospital Cancer Center, Cincinnati, Ohio Ohio State University Medical Center, Columbus, Ohio University of Pennsylvania-Abramson Cancer Center, Philadelphia, Pennsylvania Medical University of South Carolina, Charleston, South Carolina Sarah Cannon Research Institute, Chattanooga, Tennessee Age range
18 Years and older
Last updated February 2026